A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-ThalassemiaMaria Domenica Cappellini, Antonio Piga, Idit Pazgal-Kobrowski et al.|New England Journal of Medicine|2020Cited by 320
Safety and pharmacokinetics of the oral iron chelator SP‐420 in β‐thalassemiaAlì Taher, Vip Viprakasit, Antoine N. Saliba et al.|American Journal of Hematology|2017Cited by 15
The Believe Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia Patients Who Require Regular Red Blood Cell (RBC) TransfusionsMaria Domenica Cappellini, Antonio Piga, Vip Viprakasit et al.|Blood|2018Cited by 14
Luspatercept versus mitapivat for non‐transfusion‐dependent β‐thalassemia: Dare to compare?Khaled M. Musallam, Alì Taher, Sujit Sheth et al.|HemaSphere|2025Cited by 5